Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation
Author(s) -
Richard S.P. Huang,
Julie Y. Tse,
Lukas Harries,
Ryon P. Graf,
Douglas I. Lin,
Karthikeyan Murugesan,
Matthew Hiemenz,
Vamsi Parimi,
Tyler Janovitz,
Brennan Decker,
Eric A. Severson,
Mia Levy,
Shakti Ramkissoon,
Julia A. Elvin,
Jeffrey S. Ross,
Erik A. Williams
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac090
Subject(s) - cdkn2a , medicine , pten , melanoma , immunohistochemistry , cohort , oncology , metastatic melanoma , pathology , cancer research , cancer , biology , genetics , apoptosis , pi3k/akt/mtor pathway
In the current study, we examined the real-world prevalence of highly pigmented advanced melanomas (HPMel) and the clinicopathologic, genomic, and ICPI biomarker signatures of this class of tumors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom